abrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Total Revenue

Revenue analysis for HQL.

Quarterly Revenue

$48.07M

↑ 164.14% YoY

As of Mar 2026

Annual Revenue (TTM)

$136.37M

↑ 248.23% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin